デフォルト表紙
市場調査レポート
商品コード
1097914

創薬における人工知能(AI)の世界市場の機会と2031年までの戦略:COVID-19の影響と回復

Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities And Strategies To 2031: COVID-19 Growth And Change

出版日: | 発行: The Business Research Company | ページ情報: 英文 274 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.29円
創薬における人工知能(AI)の世界市場の機会と2031年までの戦略:COVID-19の影響と回復
出版日: 2022年07月07日
発行: The Business Research Company
ページ情報: 英文 274 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の創薬における人工知能(AI)市場について調査分析し、市場の特徴、市場の動向と戦略、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 創薬における人工知能(AI)市場エグゼクティブサマリー

第2章 目次

第3章 図のリスト

第4章 表のリスト

第5章 レポートの構造

第6章 イントロダクション

  • セグメンテーション:地域別
  • セグメンテーション:技術別
  • セグメンテーション:薬剤タイプ別
  • セグメンテーション:治療タイプ別
  • セグメンテーション:エンドユーザー別

第7章 創薬における人工知能(AI)市場の特徴

  • 市場の定義
  • セグメンテーション:技術別
    • コンテキストアウェア処理
    • 自然言語処理
    • クエリ方法
    • ディープラーニング
  • セグメンテーション:薬剤タイプ別
    • 小分子
    • 大分子
  • セグメンテーション:治療タイプ別
    • 代謝性疾患
    • 循環器疾患
    • 腫瘍
    • 神経変性疾患
    • 呼吸器疾患
    • 抗感染症
    • その他
  • セグメンテーション:エンドユーザー別
    • 製薬会社
    • バイオ製薬会社
    • 学術機関・研究機関
    • その他

第8章 創薬における人工知能(AI)市場の動向と戦略

  • ターゲット選択におけるAI
  • 薬物スクリーニングにおけるAI
  • 前臨床研究におけるAIベースのモデルの活用
  • 医薬品開発のためのバイオマーカーの使用
  • 創薬のための新しい人工知能(AI)ツールの採用
  • AI主導のバイオ技術企業への投資
  • 合併と買収活動の台頭
  • AIエコシステムにおけるCROの新たな役割
  • AIイノベーションラボの採用

第9章 創薬における人工知能(AI)市場に対するCOVID-19の影響

  • イントロダクション
  • COVID-19創薬におけるAIの使用
  • 規制の枠組みへの影響
  • 今後の展望

第10章 創薬における人工知能(AI)の市場規模と成長

  • 市場規模
  • 市場成長実績、金額(100万米ドル)(2016年~2021年)
    • 市場促進要因(2016年~2021年)
    • 市場抑制要因(2016年~2021年)
  • 市場成長予測、金額(100万米ドル)(2021年~2026年)(2031年)
    • 市場促進要因(2021年~2026年)
    • 市場抑制要因(2021年~2026年)

第11章 創薬における人工知能(AI)市場セグメンテーション

  • 世界の創薬における人工知能(AI)市場、実績および予測、金額(100万米ドル)(2016年~2021年)(2026年)(2031年):技術別
  • 世界の創薬における人工知能(AI)市場、実績および予測、金額(100万米ドル)(2016年~2021年)(2026年)(2031年):創薬タイプ別
  • 世界の創薬における人工知能(AI)市場、実績および予測、金額(100万米ドル)(2016年~2021年)(2026年)(2031年):治療タイプ別
  • 世界の創薬における人工知能(AI)市場、実績および予測、金額(100万米ドル)(2016年~2021年)(2026年)(2031年):エンドユーザー別

第12章 創薬における人工知能(AI)市場、地域および国の分析

  • 世界の創薬における人工知能(AI)市場、実績および予測、金額(100万米ドル)(2016年~2021年)(2026年)(2031年):地域別
  • 世界の創薬における人工知能(AI)市場、実績および予測、金額(100万米ドル)(2016年~2021年)(2026年)(2031年):国別

第13章 アジア太平洋の創薬における人工知能(AI)市場

第14章 西欧の創薬における人工知能(AI)市場

第15章 東欧の創薬における人工知能(AI)市場

第16章 北米の創薬における人工知能(AI)市場

第17章 南米の創薬における人工知能(AI)市場

第18章 中東の創薬における人工知能(AI)市場

第19章 アフリカの創薬における人工知能(AI)市場

第20章 創薬における人工知能(AI)市場の競合情勢

  • 企業プロファイル
  • IBM Corporation
  • Benevolent AI
  • Nvidia Corporation
  • Exscientia
  • Concreto HealthAI

第21章 創薬における人工知能(AI)市場における主要な合併と買収

  • X-ChemがGlamorous AIを買収
  • Philip MorrisがOtiTopicを買収
  • Exscientiaがオーストリアの会社Allcyteを買収
  • Valo HealthがKhosla Venturesと合併
  • Relay TherapeuticsがZebiAIを買収
  • PathAIがLabcorpと合併
  • Sema4はCCM Life Sciencesと合併
  • Curi bioがDana solutionsを買収

第22章 創薬における人工知能(AI)市場の機会と戦略

  • 世界の創薬における人工知能(AI)市場-成長国(2026年)
  • 世界の創薬における人工知能(AI)市場-成長セグメント(2026年)
  • 世界の創薬における人工知能(AI)市場-成長戦略(2026年)
    • 市場動向ベースの戦略
    • 競合企業の戦略

第23章 創薬における人工知能(AI)市場、結論・提言

  • 結論
  • 推奨事項
    • 製品
    • 場所
    • 価格
    • プロモーション

第24章 付録

目次
Product Code: o&s448

Artificial Intelligence (AI) In Drug Discovery Global Market Opportunities And Strategies To 2031: COVID-19 Growth And Change from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global artificial intelligence (AI) in drug discovery market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.

Where is the largest and fastest growing market for artificial intelligence (AI) in drug discovery? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The artificial intelligence (AI) in drug discovery market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider artificial intelligence (AI) in drug discovery market; and compares it with other markets.

The report covers the following chapters:

Executive Summary - The executive summary section of the report gives a brief overview and summary of the report.

Report Structure - This section gives the structure of the report and the information covered in the various sections.

Introduction - The introduction section of the report gives a brief introduction about segmentation by geography, segmentation by technology, segmentation by drug type, segmentation by therapeutic type, and segmentation by end-users.

Market Characteristics - The market characteristics section of the report defines and explains the artificial intelligence (AI) in drug discovery market. This chapter also defines and describes goods and related services covered in the report.

Trends And Strategies - This chapter describes the major trends shaping the global artificial intelligence (AI) in drug discovery market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.

Impact of COVID-19 - This section describes the impact of COVID-19 on the artificial intelligence (AI) in drug discovery market.

Global Market Size And Growth - This section contains the global historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.

Regional Analysis - This section contains the historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values and growth and market share comparison by region.

Segmentation - This section contains the market values (2016-2031) and analysis for different segments.

Regional Market Size and Growth - This section contains the region's market size (2021), historic (2016-2021) and forecast (2021-2026), and (2026-2031) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa, and major countries within each region. The market overview sections of the report describe the current size of the market, background information, government initiatives, regulations, regulatory bodies, associations, corporate tax structure, investments, and major companies.

Competitive Landscape - This section covers details on the competitive landscape of the global artificial intelligence (AI) in drug discovery market, estimated market shares, and company profiles for the leading players.

Key Mergers And Acquisitions - This chapter gives information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.

Market Opportunities And Strategies - This section includes market opportunities and strategies based on findings of the research. This section also gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.

Conclusions And Recommendations - This section includes conclusions and recommendations based on findings of the research. This section also gives recommendations for artificial intelligence (AI) in drug discovery market in terms of product/service offerings, geographic expansion, marketing strategies and target groups.

Appendix - This section includes details on the NAICS (North American Industry Classification System) codes covered, abbreviations, and currencies codes used in this report.

Scope

Markets Covered: 1) By Technology: Context-Aware Processing; Natural Language Processing; Querying Method; Deep Learning

2) By Drug Type: Small Molecule; Large Molecules

3) By Therapeutic Type: Metabolic Disease; Cardiovascular Disease; Oncology; Neurodegenerative Diseases; Respiratory Diseases; Anti-Infective Diseases; Other Therapeutic Areas

4) By End-Users: Pharmaceutical Companies; Biopharmaceutical Companies; Academic And Research Institutes; Others

Companies Mentioned: IBM Corporation; Benevolent AI; Nvidia Corporation; Exscientia ; Concreto HealthAI

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; artificial intelligence (AI) in drug discovery indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Artificial Intelligence (AI) In Drug Discovery Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction

  • 6.1. Segmentation By Geography
  • 6.2. Segmentation By Technology
  • 6.3. Segmentation By Drug Type
  • 6.4. Segmentation By Therapeutic Type
  • 6.5. Segmentation By End-Users

7. Artificial Intelligence (AI) In Drug Discovery Market Characteristics

  • 7.1. Market Definition
  • 7.2. Segmentation By Technology
    • 7.2.1. Context-Aware Processing
    • 7.2.2. Natural Language Processing
    • 7.2.3. Querying Method
    • 7.2.4. Deep Learning
  • 7.3. Segmentation By Drug Type
    • 7.3.1. Small Molecule
    • 7.3.2. Large Molecule
  • 7.4. Segmentation By Therapeutic Type
    • 7.4.1. Metabolic Diseases
    • 7.4.2. Cardiovascular Disease
    • 7.4.3. Oncology
    • 7.4.4. Neurodegenerative Diseases
    • 7.4.5. Respiratory Diseases
    • 7.4.6. Anti-Infective Diseases
    • 7.4.7. Others
  • 7.5. Segmentation By End-Users
    • 7.5.1. Pharmaceutical Companies
    • 7.5.2. Biopharmaceutical Companies
    • 7.5.3. Academic And Research Institutes
    • 7.5.4. Others

8. Artificial Intelligence (AI) In Drug Discovery Market Trends And Strategies

  • 8.1. AI in Target Selection
  • 8.2. AI in Drug Screening
  • 8.3. Leveraging AI Based Models in Pre-Clinical Studies
  • 8.4. Use Of Biomarker For Drug Development
  • 8.5. Introduction of New Artificial Intelligence (AI) Tools For Drug Discovery
  • 8.6. Investments in AI Driven Biotech Firms
  • 8.7. Rise In Merger And Acquisition Activity
  • 8.8. Emerging Role of CROs in AI Ecosystems
  • 8.9. Introduction of AI Innovation Labs

9. Impact Of COVID-19 On Artificial Intelligence (AI) In Drug Discovery

  • 9.1. Introduction
  • 9.2. Use of AI In COVID-19 Drug Discovery
  • 9.3. Impact On Regulatory Framework
  • 9.4. Future Outlook

10. Global Artificial Intelligence (AI) In Drug Discovery Market Size And Growth

  • 10.1. Market Size
  • 10.2. Historic Market Growth, 2016 - 2021, Value ($ Million)
    • 10.2.1. Drivers Of The Market 2016 - 2021
    • 10.2.2. Restraints On The Market 2016 - 2021
  • 10.3. Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
    • 10.3.1. Drivers Of The Market 2021 - 2026
    • 10.3.2. Restraints On The Market 2021 - 2026

11. Global Artificial Intelligence (AI) In Drug Discovery Market Segmentation

  • 11.1. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.2. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.3. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Therapeutic Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 11.4. Global Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-Users, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

12. Artificial Intelligence (AI) In Drug Discovery Market, Regional And Country Analysis

  • 12.1. Global Artificial Intelligence (AI) In Drug Discovery Market, By Region, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 12.2. Global Artificial Intelligence (AI) In Drug Discovery Market, By Country, Historic and Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

13. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market

  • 13.1. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market Overview
    • 13.1.1. Region Information
    • 13.1.2. Market Information
    • 13.1.3. Background Information
    • 13.1.4. Government Initiatives
    • 13.1.5. Regulations
    • 13.1.6. Regulatory Bodies
    • 13.1.7. Major Associations
    • 13.1.8. Taxes levied
    • 13.1.9. Corporate Tax Structure
    • 13.1.10. Investments
    • 13.1.11. Major Companies
  • 13.2. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 13.3. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 13.4. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.5. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.6. Asia-Pacific Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
  • 13.7. China Artificial Intelligence (AI) In Drug Discovery Market
  • 13.8. China Artificial Intelligence (AI) In Drug Discovery Market Overview
    • 13.8.1. Country Information
    • 13.8.2. Market Information
    • 13.8.3. Background Information
    • 13.8.4. Government Initiatives
    • 13.8.5. Regulations
    • 13.8.6. Regulatory Bodies
    • 13.8.7. Major Associations
    • 13.8.8. Taxes Levied
    • 13.8.9. Corporate Tax Structure
    • 13.8.10. Investments
    • 13.8.11. Major Companies
  • 13.9. China Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 13.10. China Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 13.11. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.12. China Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.13. India Artificial Intelligence (AI) In Drug Discovery Market
  • 13.14. India Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 13.15. India Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 13.16. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.17. India Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.18. Japan Artificial Intelligence (AI) In Drug Discovery Market
  • 13.19. Japan Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 13.20. Japan Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 13.21. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.22. Japan Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.23. Australia Artificial Intelligence (AI) In Drug Discovery Market
  • 13.24. Australia Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 13.25. Australia Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 13.26. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.27. Australia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.28. Indonesia Artificial Intelligence (AI) In Drug Discovery Market
  • 13.29. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 13.30. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 13.31. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.32. Indonesia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.33. South Korea Artificial Intelligence (AI) In Drug Discovery Market
  • 13.34. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 13.35. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 13.36. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 13.37. South Korea Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

14. Western Europe Artificial Intelligence (AI) In Drug Discovery Market

  • 14.1. Western Europe Artificial Intelligence (AI) In Drug Discovery Market Overview
    • 14.1.1. Region Information
    • 14.1.2. Market Information
    • 14.1.3. Background Information
    • 14.1.4. Government Initiatives
    • 14.1.5. Regulations
    • 14.1.6. Major Associations
    • 14.1.7. Taxes Levied
    • 14.1.8. Corporate Tax Structure
    • 14.1.9. Investments
    • 14.1.10. Major Companies
  • 14.2. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 14.3. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 14.4. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 14.5. Western Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 14.6. Western Europe Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
  • 14.7. UK Artificial Intelligence (AI) In Drug Discovery Market
  • 14.8. UK Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 14.9. UK Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 14.10. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 14.11. UK Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 14.12. Germany Artificial Intelligence (AI) In Drug Discovery Market
  • 14.13. Germany Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 14.14. Germany Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 14.15. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 14.16. Germany Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 14.17. France Artificial Intelligence (AI) In Drug Discovery Market
  • 14.18. France Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 14.19. France Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 14.20. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 14.21. France Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

15. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market

  • 15.1. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market Overview
    • 15.1.1. Region Information
    • 15.1.2. Market Information
    • 15.1.3. Background Information
    • 15.1.4. Government Initiatives
    • 15.1.5. Regulations
    • 15.1.6. Regulatory Bodies
    • 15.1.7. Major Associations
    • 15.1.8. Taxes Levied
    • 15.1.9. Corporate Tax Structure
    • 15.1.10. Investments
    • 15.1.11. Major Companies
  • 15.2. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 15.3. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 15.4. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 15.5. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 15.6. Eastern Europe Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
  • 15.7. Russia Artificial Intelligence (AI) In Drug Discovery Market
  • 15.8. Russia Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 15.9. Russia Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 15.10. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 15.11. Russia Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

16. North America Artificial Intelligence (AI) In Drug Discovery Market

  • 16.1. North America Artificial Intelligence (AI) In Drug Discovery Market Overview
    • 16.1.1. Region Information
    • 16.1.2. Market Information
    • 16.1.3. Background Information
    • 16.1.4. Government Initiatives
    • 16.1.5. Regulations
    • 16.1.6. Regulatory Bodies
    • 16.1.7. Major Associations
    • 16.1.8. Taxes Levied
    • 16.1.9. Corporate Tax Structure
    • 16.1.10. Investments
    • 16.1.11. Major Companies
  • 16.2. North America Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 16.3. North America Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 16.4. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 16.5. North America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 16.6. North America Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
  • 16.7. USA Artificial Intelligence (AI) In Drug Discovery Market
  • 16.8. USA Artificial Intelligence (AI) In Drug Discovery Market Overview
    • 16.8.1. Country Information
    • 16.8.2. Market Information
    • 16.8.3. Background Information
    • 16.8.4. Government Initiatives
    • 16.8.5. Regulations
    • 16.8.6. Regulatory Bodies
    • 16.8.7. Major Associations
    • 16.8.8. Taxes Levied
    • 16.8.9. Corporate Tax Structure
    • 16.8.10. Investments
    • 16.8.11. Major Companies
  • 16.9. USA Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 16.10. USA Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 16.11. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 16.12. USA Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

17. South America Artificial Intelligence (AI) In Drug Discovery Market

  • 17.1. South America Artificial Intelligence (AI) In Drug Discovery Market Overview
    • 17.1.1. Region Information
    • 17.1.2. Market Information
    • 17.1.3. Background Information
    • 17.1.4. Government Initiatives
    • 17.1.5. Regulations
    • 17.1.6. Regulatory Bodies
    • 17.1.7. Major Associations
    • 17.1.8. Taxes Levied
    • 17.1.9. Corporate Tax Structure
    • 17.1.10. Investments
    • 17.1.11. Major Companies
  • 17.2. South America Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 17.3. South America Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 17.4. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 17.5. South America Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 17.6. South America Artificial Intelligence (AI) In Drug Discovery Market: Country Analysis
  • 17.7. Brazil Artificial Intelligence (AI) In Drug Discovery Market
  • 17.8. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 17.9. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 17.10. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 17.11. Brazil Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

18. Middle East Artificial Intelligence (AI) In Drug Discovery Market

  • 18.1. Middle East Artificial Intelligence (AI) In Drug Discovery Market Overview
    • 18.1.1. Region Information
    • 18.1.2. Market Information
    • 18.1.3. Background Information
    • 18.1.4. Government Initiatives
    • 18.1.5. Regulations
    • 18.1.6. Regulatory Bodies
    • 18.1.7. Major Associations
    • 18.1.8. Taxes Levied
    • 18.1.9. Corporate Tax Structure
    • 18.1.10. Investments
    • 18.1.11. Major Companies
  • 18.2. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 18.3. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 18.4. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 18.5. Middle East Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

19. Africa Artificial Intelligence (AI) In Drug Discovery Market

  • 19.1. Africa Artificial Intelligence (AI) In Drug Discovery Market Overview
    • 19.1.1. Region Information
    • 19.1.2. Market Information
    • 19.1.3. Background Information
    • 19.1.4. Government Initiatives
    • 19.1.5. Regulations
    • 19.1.6. Regulatory Bodies
    • 19.1.7. Major Associations
    • 19.1.8. Taxes levied
    • 19.1.9. Corporate Tax Structure
    • 19.1.10. Investments
    • 19.1.11. Major Companies
  • 19.2. Africa Artificial Intelligence (AI) In Drug Discovery Market, Historic Market Growth, 2016 - 2021, Value ($ Million)
  • 19.3. Africa Artificial Intelligence (AI) In Drug Discovery Market, Forecast Market Growth, 2021 - 2026, 2031F Value ($ Million)
  • 19.4. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)
  • 19.5. Africa Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Drug Type, Historic And Forecast, 2016 - 2021, 2026F, 2031F, Value ($ Million)

20. Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape

  • 20.1. Company Profiles
  • 20.2. IBM Corporation
    • 20.2.1. Company Overview
    • 20.2.2. Products And Services
    • 20.2.3. Business Strategy
    • 20.2.4. Financial Overview
  • 20.3. Benevolent AI
    • 20.3.1. Company Overview
    • 20.3.2. Products And Services
    • 20.3.3. Business Strategy
    • 20.3.4. Financial Overview
  • 20.4. Nvidia Corporation
    • 20.4.1. Company Overview
    • 20.4.2. Products And Services
    • 20.4.3. Business Strategy
    • 20.4.4. Financial Overview
  • 20.5. Exscientia
    • 20.5.1. Company Overview
    • 20.5.2. Products And Services
    • 20.5.3. Business Strategy
    • 20.5.4. Financial Overview
  • 20.6. Concreto HealthAI
    • 20.6.1. Company Overview
    • 20.6.2. Products And Services
    • 20.6.3. Business Strategy
    • 20.6.4. Financial Overview

21. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Drug Discovery Market

  • 21.1. X-Chem Acquired Glamorous AI
  • 21.2. Philip Morris Acquired OtiTopic
  • 21.3. Exscientia Acquired Austrian Company Allcyte
  • 21.4. Valo Health merged with Khosla Ventures Acquisition
  • 21.5. Relay Therapeutics acquired ZebiAI
  • 21.6. PathAI Merged with Labcorp
  • 21.7. Sema4 Merged with CM Life Sciences
  • 21.8. Curi bio Acquired Dana solutions

22. Artificial Intelligence (AI) In Drug Discovery Market Opportunities And Strategies

  • 22.1. Global Artificial Intelligence (AI) In Drug Discovery Market In 2026 - Countries Offering Most New Opportunities
  • 22.2. Global Artificial Intelligence (AI) In Drug Discovery Market In 2026 - Segments Offering Most New Opportunities
  • 22.3. Global Artificial Intelligence (AI) In Drug Discovery Market In 2026 - Growth Strategies
    • 22.3.1. Market Trend Based Strategies
    • 22.3.2. Competitor Strategies

23. Artificial Intelligence (AI) In Drug Discovery Market, Conclusions And Recommendations

  • 23.1. Conclusions
  • 23.2. Recommendations
    • 23.2.1. Product
    • 23.2.2. Place
    • 23.2.3. Price
    • 23.2.4. Promotion
    • 23.2.5. People

24. Appendix

  • 24.1. Market Data Sources
  • 24.2. Research Methodology
  • 24.3. Currencies
  • 24.4. Research Inquiries
  • 24.5. The Business Research Company
  • 24.6. Copyright And Disclaimer